Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders.
Adult
Basic Helix-Loop-Helix Transcription Factors
/ genetics
Bone Morphogenetic Protein 4
/ genetics
Cells, Cultured
Craniofacial Abnormalities
/ genetics
Cyclic AMP Response Element-Binding Protein A
/ genetics
Hedgehog Proteins
/ genetics
Humans
Male
Mediator Complex
/ chemistry
Mental Retardation, X-Linked
/ genetics
Middle Aged
Mutation, Missense
Nerve Tissue Proteins
/ genetics
Pedigree
Protein Domains
Signal Transduction
MED12
Mutation
SHH Signaling
XLID
qRT-PCR
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
20
07
2018
revised:
05
12
2018
accepted:
11
12
2018
pubmed:
8
2
2019
medline:
22
5
2019
entrez:
8
2
2019
Statut:
ppublish
Résumé
Mutations in mediator of RNA polymerase II transcription subunit 12 homolog (MED12, OMIM 300188) cause X-linked intellectual disability (XLID) disorders including FG, Lujan, and Ohdo syndromes. The Gli3-dependent Sonic Hedgehog (SHH) signaling pathway has been implicated in the original FG syndrome and Lujan syndrome. How are SHH-signaling defects related to the complex clinical phenotype of MED12-associated XLID syndromes are not fully understood. Quantitative RT-PCR was used to study expression levels of three SHH-signaling genes in lymophoblast cell lines carrying four MED12 mutations from four unrelated XLID families. Genotype and phenotype correlation studies were performed on these mutations. Three newly identified and one novel MED12 mutations in six affected males from four unrelated XLID families were studied. Three mutations (c.2692A>G; p.N898D, c.3640C>T; p.R1214C, and c.3884G>A; p.R1295H) are located in the LS domain and one (c.617G>A; p.R206Q) is in the L domain of MED12. These mutations involve highly conserved amino acid residues and segregate with ID and related congenital malformations in respective probands families. Patients with the LS-domain mutations share many features of FG syndrome and some features of Lujan syndrome. The patient with the L-domain mutation presented with ID and predominant neuropsychiatric features but little dysmorphic features of either FG or Lujan syndrome. Transcript levels of three Gli3-dependent SHH-signaling genes, CREB5, BMP4, and NEUROG2, were determined by quantitative RT-PCR and found to be significantly elevated in lymphoblasts from patients with three mutations in the MED12-LS domain. These results support a critical role of MED12 in regulating Gli3-dependent SHH signaling and in developing ID and related congenital malformations in XLID syndromes. Differences in the expression profile of SHH-signaling genes potentially contribute to variability in clinical phenotypes in patients with MED12-related XLID disorders.
Sections du résumé
BACKGROUND
Mutations in mediator of RNA polymerase II transcription subunit 12 homolog (MED12, OMIM 300188) cause X-linked intellectual disability (XLID) disorders including FG, Lujan, and Ohdo syndromes. The Gli3-dependent Sonic Hedgehog (SHH) signaling pathway has been implicated in the original FG syndrome and Lujan syndrome. How are SHH-signaling defects related to the complex clinical phenotype of MED12-associated XLID syndromes are not fully understood.
METHODS
Quantitative RT-PCR was used to study expression levels of three SHH-signaling genes in lymophoblast cell lines carrying four MED12 mutations from four unrelated XLID families. Genotype and phenotype correlation studies were performed on these mutations.
RESULTS
Three newly identified and one novel MED12 mutations in six affected males from four unrelated XLID families were studied. Three mutations (c.2692A>G; p.N898D, c.3640C>T; p.R1214C, and c.3884G>A; p.R1295H) are located in the LS domain and one (c.617G>A; p.R206Q) is in the L domain of MED12. These mutations involve highly conserved amino acid residues and segregate with ID and related congenital malformations in respective probands families. Patients with the LS-domain mutations share many features of FG syndrome and some features of Lujan syndrome. The patient with the L-domain mutation presented with ID and predominant neuropsychiatric features but little dysmorphic features of either FG or Lujan syndrome. Transcript levels of three Gli3-dependent SHH-signaling genes, CREB5, BMP4, and NEUROG2, were determined by quantitative RT-PCR and found to be significantly elevated in lymphoblasts from patients with three mutations in the MED12-LS domain.
CONCLUSIONS
These results support a critical role of MED12 in regulating Gli3-dependent SHH signaling and in developing ID and related congenital malformations in XLID syndromes. Differences in the expression profile of SHH-signaling genes potentially contribute to variability in clinical phenotypes in patients with MED12-related XLID disorders.
Identifiants
pubmed: 30729724
doi: 10.1002/mgg3.569
pmc: PMC6465656
doi:
Substances chimiques
BMP4 protein, human
0
Basic Helix-Loop-Helix Transcription Factors
0
Bone Morphogenetic Protein 4
0
CREB5 protein, human
0
Cyclic AMP Response Element-Binding Protein A
0
Hedgehog Proteins
0
MED12 protein, human
0
Mediator Complex
0
NEUROG2 protein, human
0
Nerve Tissue Proteins
0
SHH protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00569Informations de copyright
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Références
Hum Genome Var. 2015 Jun 18;2:15018
pubmed: 27081531
Genet Med. 2009 Nov;11(11):769-75
pubmed: 19938245
Curr Opin Neurobiol. 2002 Feb;12(1):57-63
pubmed: 11861165
Eur J Hum Genet. 2015 Nov;23(11):1513-8
pubmed: 25649377
PLoS One. 2015 Feb 13;10(2):e0116454
pubmed: 25679214
Am J Hum Genet. 2013 Mar 7;92(3):401-6
pubmed: 23395478
Clin Genet. 2013 Dec;84(6):507-21
pubmed: 23506379
J Med Genet. 2007 Jul;44(7):472-7
pubmed: 17369503
Prostate. 2016 Jan;76(1):22-31
pubmed: 26383637
Am J Med Genet A. 2015 Dec;167A(12):3180-5
pubmed: 26338144
Clin Case Rep. 2015 Jul;3(7):604-9
pubmed: 26273451
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17284-9
pubmed: 17088561
Am J Hum Genet. 2000 Nov;67(5):1047-54
pubmed: 11001584
Mol Cell Biol. 2006 Dec;26(23):8667-82
pubmed: 17000779
Clin Genet. 2018 Nov;94(5):450-456
pubmed: 30006928
Hum Mol Genet. 2017 Jun 1;26(11):2062-2075
pubmed: 28369444
Am J Med Genet A. 2013 Dec;161A(12):3063-71
pubmed: 24039113
Development. 2010 Aug;137(16):2723-31
pubmed: 20630950
Am J Med Genet. 1984 Jan;17(1):311-22
pubmed: 6711603
Am J Hum Genet. 2007 May;80(5):982-7
pubmed: 17436253
Z Kinderheilkd. 1974 Apr 8;117(1):1-18
pubmed: 4365204
Mod Pathol. 2013 May;26(5):743-9
pubmed: 23222489
Mol Genet Genomic Med. 2019 Apr;7(4):e00569
pubmed: 30729724
Mol Cell. 2008 Aug 8;31(3):347-59
pubmed: 18691967
Nat Genet. 2009 May;41(5):535-43
pubmed: 19377476
Am J Med Genet A. 2013 Nov;161A(11):2734-40
pubmed: 24123922
Am J Med Genet A. 2014 Jul;164A(7):1821-5
pubmed: 24715367
Dev Biol. 2008 May 15;317(2):467-79
pubmed: 18394596
Development. 2014 Mar;141(5):977-87
pubmed: 24550107
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19763-8
pubmed: 23091001
Nat Genet. 2007 Apr;39(4):451-3
pubmed: 17334363